Proteinuria and rate of change in kidney function in a community-based population

Journal of the American Society of Nephrology

Volumn 24, Issue 10, 2013, Pages 1661-1667

  Turin, Tanvir Chowdhury ^a   James, Matthew ^a,b   Ravani, Pietro ^a,b   Tonelli, Marcello ^c   Manns, Braden J ^a,b   Quinn, Robert ^a,b   Jun, Min ^b   Klarenbach, Scott ^c   Hemmelgarn, Brenda R ^a,c  

^a FOOTHILLS HOSPITAL   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; ARTICLE; CANADA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEINURIA; TREND STUDY;

EID: 84885066673     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012111118     Document Type: Article

References (32)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
2. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the american heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 108: 2154-2169, 2003
3. Eriksen BO, Ingebretsen OC: The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age. Kidney Int 69: 375-382, 2006
4. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164: 659-663, 2004
5. Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali WA, Southern DA, McLaughlin K, Mortis G, Culleton BF: Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 69: 2155-2161, 2006
6. Halbesma N, Kuiken DS, Brantsma AH, Bakker SJL, Wetzels JFM, De Zeeuw D, De Jong PE, Gansevoort RT: Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol 17: 2582-2590, 2006
7. Culleton BF, Larson MG, Parfrey PS, Kannel WB, Levy D: Proteinuria as a risk factor for cardiovascular disease and mortality in older people: A prospective study. Am J Med 109: 1-8, 2000
8. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, Marcantoni C, de Jong PE, de Zeeuw D, Shahinfar S, Ruggenenti P, Remuzzi G, Levey AS; AIPRD Study Group. Angiotensin-converting enzymne inhibition and progression of renal disease: Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int 60: 1131-1140, 2001
9. Lea J, Greene T, Hebert L, Lipkowitz M, Massry S, Middleton J, Rostand SG, Miller E, Smith W, Bakris GL: The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: Results of the African American study of kidney disease and hypertension. Arch Intern Med 165: 947-953, 2005
10. van der Velde M, Halbesma N, de Charro FT, Bakker SJL, de Zeeuw D, de Jong PE, Gansevoort RT: Screening for albuminuria identifies individuals at increased renal risk. J Am Soc Nephrol 20: 852-862, 2009
11. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 375: 2073-2081, 2010
12. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M; Alberta Kidney Disease Network: Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303: 423-429, 2010
13. Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, Orth SR: Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 20: 1069-1077, 2009
14. Ciavarella A, Silletti A, Forlani G, Morotti L, Borgnino LC, D'Apote M, Vannini P: A screening test for microalbuminuria in type 1 (insulin-dependent) diabetes. Diabetes Res Clin Pract 7: 307-312, 1989
15. Eknoyan G, Levin NW; National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 [Suppl 1]: S1-S266, 2002
16. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression of nondiabetic renal disease: A meta-analysis. J Am Soc Nephrol 11: 319-329, 2000
17. Seliger SL, Davis C, Stehman-Breen C: Gender and the progression of renal disease. Curr Opin Nephrol Hypertens 10: 219-225, 2001
18. Jafar TH, Schmid CH, Stark PC, Toto R, Remuzzi G, Ruggenenti P, Marcantoni C, Becker G, Shahinfar S, De Jong PE, De Zeeuw D, Kamper AL, Strangaard S, Levey AS: The rate of progression of renal disease may not be slower in women compared withmen: A patient-levelmetaanalysis. Nephrol Dial Transplant 18: 2047-2053, 2003
19. Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR, El-Achkar TM, Balasubramanian S, Nurutdinova D, Xian H, Stroupe K, Abbott KC, Eisen S: Rate of kidney function decline associates with mortality. J Am Soc Nephrol 21: 1961-1969, 2010
20. Bland JM, Altman DG: Some examples of regression towards themean. BMJ 309: 780, 1994
21. Barnett AG, van der Pols JC, Dobson AJ: Regression to the mean: What it is and how to deal with it. Int J Epidemiol 34: 215-220, 2005
22. Hemmelgarn BR, Clement F, Manns BJ, Klarenbach S, James MT, Ravani P, Pannu N, Ahmed SB, MacRae J, Scott-Douglas N, Jindal K, Quinn R, Culleton BF, Wiebe N, Krause R, Thorlacius L, Tonelli M: Overview of the Alberta Kidney Disease Network. BMC Nephrol 10: 30, 2009
23. Manns BJ, Mortis GP, Taub KJ, McLaughlin K, Donaldson C, Ghali WA: The Southern Alberta Renal Program database: A prototype for patient management and research initiatives. Clin Invest Med 24: 164-170, 2001
24. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease EpidemiologyCollaboration): Anewequation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
25. Census Canada: 2006 Census of Population. Available at: http://www12. Statcan. Ca/english/census06/data/highlights/ethnic/index. Cfm?Lang=e%3E. Accessed June 15, 2009
26. Lamb EJ, MacKenzie F, Stevens PE: How should proteinuria be detected and measured? Ann Clin Biochem 46: 205-217, 2009
27. Sin DD, Svenson LW, Cowie RL, Man SF: Can universal access to health care eliminate health inequities between children of poor and nonpoor families? A case study of childhood asthma in Alberta. Chest 124: 51-56, 2003
28. Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: Determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 25: 512-516, 2002
29. Quan H, Khan N, Hemmelgarn BR, Tu K, Chen G, Campbell N, Hill MD, Ghali WA, McAlister FA; Hypertension Outcome and Surveillance Team of the Canadian Hypertension Education Programs: Validation of a case definition to define hypertension using administrative data. Hypertension 54: 1423-1428, 2009
30. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA: Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43: 1130-1139, 2005
31. Sun GW, Shook TL, Kay GL: Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol 49: 907-916, 1996
32. Silbiger SR, Neugarten J: The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 25: 515-533, 1995